INCR -- Incara Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : INCR -- Incara Pharmaceuticals

INCR 1.140

-5.0%

Dec 24 12:55 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Findit who wrote (182)	9/20/2002 11:43:44 AM
From: tuck	Read Replies (1) of 196

>>Bennett also noted that potential investors who have looked at the business are more interested in the company's other development projects. Incara, which doesn't yet have any products on the market, also is developing treatments for liver failure and for damage caused by cancer radiation therapy and stroke.<< Not sure about the liver stem cell program, but the anti-oxidant program might be worth something to someone. Rick probably has a better idea if it's worth .10/share and who might be interested. IMO, a munch for the cancer program is the best thing that could happen, maybe selling the liver stem cell program to STEM or maybe GERN or . . . well, they probably can't afford to buy anything. The technology needs to be in the hands of a non-virtual company that can move faster with development. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next